Brainsway Ltd - ADR Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTHigh rank
12Positive7Negative
63.2% Pass in checklist
Check P/E Buy Sell Zone
Not enough data available
Brainsway Ltd - ADR Stock Price Analysis
Day Price Range | 8 (LTP) 7.88.4 LowHigh |
Week Price Range | 8 (LTP) 7.88.8 LowHigh |
Month Price Range | 8 (LTP) 7.810.2 LowHigh |
52 Week Price Range | 8 (LTP) 4.611.8 LowHigh |
Brainsway Ltd - ADR Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Brainsway Ltd - ADR's Revenue was higher than average estimate 2 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 33.3% in FY25
Consensus Recommendation
3 ANALYST Recommendations
STRONG BUY
The consensus recommendation from 3 analysts for Brainsway Ltd - ADR is STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Brainsway Ltd - ADR Stock Analysis
Brainsway Ltd - ADR stock analysis with key metrics, changes, and trends.
Brainsway Ltd - ADR Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $41.02 M | 29.04% | positive |
| |
Annual Net Profit | $2.92 M | 169.6% | positive |
| |
Price to Earning Ratio | 51.61 | - | negative |
| |
Stock Price | $7.99 | 64.07% | positive |
| |
Quarterly Revenue | $11.41 M | 26.41% | positive |
| |
Quarterly Net profit | $1.55 M | 1118.9% | positive |
| |
Return on Equity(ROE) | 5.62 % | 5.62% | negative |
| |
Mutual Fund Holding | 2.60 % | 0.01% | positive |
| |
Interest Coverage Ratio | 3.28 | - | positive |
| |
Institutional Holding | 29.39 % | 0.04% | positive |
|
Loading data..
Brainsway Ltd - ADR - Company Profile
What does Brainsway Ltd - ADR do?
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Brainsway Ltd - ADR Management structure
All Gross Remunerations are in USD
Brainsway Ltd - ADR Board of directors
All Gross Remunerations are in USD